ArticleOncology letters2020

miR-30a-3p inhibits the proliferation of liver cancer cells by targeting DNMT3a through the PI3K/AKT signaling pathway.

Qiong Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.